These effects were reversed by blocking the TLR9, thus demonstrating the involvement of the mt-cfDNA and the innate immune system pattern recognition receptor TLR9 in the pathogenesis of hypertension and endothelial dysfunction. The gene discussed is TLR9; the disease is hypertensive disorder.